首页/数据集/Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

NIAID Data Ecosystem2026-03-12 收录

结直肠癌肝转移治疗

药物洗脱珠TACE术前辅助

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2379485 数据链接链接失效反馈

官方服务：

资源简介：

Trans arterial chemoembolization using Irinotecan Drug-eluting Beads before liver surgery for patients with primarily unresectable colorectal liver metastasis

应用场景：

创建时间：

2021-08-15

结直肠癌肝转移治疗

肿瘤临床试验

Interventions: Treatment is administered every 2 weeks until evidence of DLT, progression, unacceptable toxicity, patient refusal, or for a maximum of 2 cycles to assess the feasibility. (phase I) Tre

NIAID Data Ecosystem60

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

结直肠癌肝转移治疗

肝动脉灌注化疗

Background: Many people with colorectal cancer get liver metastases. Standard treatment for this is a combination of chemotherapy drugs. Directing the chemotherapy to the liver may be effective. A dev

NIAID Data Ecosystem60

Randomized pahse III study evaluating the efficacy of hepatic arterial infusion chemotherapy for metastatic colorectal cancer patients with unresectable liver metastases

结直肠癌肝转移治疗

肝动脉灌注治疗

Interventions: In the tested group, after the radiological placement of port and catheter system, hepatic arterial infusion using 5FU is performed within 6 months at the longest, and then FOLFOX+Bevac

NIAID Data Ecosystem30

The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

结直肠癌肝转移治疗

精准医疗模型

establishment and validation of the prediction model of avastin plus chemotherapy as first line treatment in simultaneous ras mutant unresectable CRLM patients

NIAID Data Ecosystem60

Intra-arterial hepatic beads loaded with irinotecan (Debiri) with concomitant chemotherapy with FOLFOX in patients with colorectal cancer with unresectable liver metastases: a phase II multicenter study

结直肠癌肝转移治疗

生存率评估

Primary objectives: Taux de survie sans progression à 9 mois selon RECIST 1.1. Primary endpoints: Le critère de jugement principal sera d’évaluer la proportion de patients vivants sans progression (le

NIAID Data Ecosystem40

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

资源简介：

相关数据集